NATIONAL CANCER RESEARCH INSTITUTE

Registered charity 1160609 · accounts filings on the Charity Commission register

The advancement of health, in particular to promote and protect the health of the public by coordinating research into the causes, prevention, treatment and cure of all forms of cancer and into the needs of people affected by cancer. And to promote collaboration between cancer research funders in the UK to maximise the value and benefits of cancer research for the benefit of the public.

Causes: The Advancement Of Health Or Saving Of Lives · Get email alerts

Latest income
£1.6m
Latest spending
£1.8m
Registered
2015
Accounts read
FY2022

Financial health, per its FY2022 accounts

The accounts state that total income for the year was £1.6m, while total expenditure was £1.8m, resulting in a net deficit of £194,340. Per the trustees' report, unrestricted reserves stood at £970,651, which is in excess of the stated policy target range of £554,000–£692,000.

Automated summary of the FY2022 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Partner membership contribution (78% of income)
“NCRI’s Partner membership remains the primary source of income. Breakdown of underlying income £1.6m Membership Contribution 78%” — page 24
Per its FY2022 accounts as filed with the Charity Commission.

Accounts audited by Sayer Vincent LLP. Discloses 2 of 6 completeness components.

Structured financials (annual return, FY ending 31/03/2022)

Total income
£1.6m
Total spending
£1.8m
Reserves (reported)
£1.1m
Employees
26

Reported reserves equal ~7.6 months of spending — above the median for charities its size (median 4.8 months; benchmarks).

Per its annual return, cost of raising funds: 0.0% of total income — below the median for charities its size (5.2%) (benchmarks).

Register events

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/03/2025——
31/03/2024——
31/03/2023——
31/03/2022£1.6m£1.8m
31/03/2021£1.5m£1.8m

Common questions

Is NATIONAL CANCER RESEARCH INSTITUTE financially healthy?

Per its FY2022 accounts: The accounts state that total income for the year was £1.6m, while total expenditure was £1.8m, resulting in a net deficit of £194,340. Per the trustees' report, unrestricted reserves stood at £970,651, which is in excess of the stated policy target range of £554,000–£692,000. Its FY2022 accounts were audited by Sayer Vincent LLP.

Funders of similar charities

Funders whose accounts show grants to charities similar to this one (and no recorded grant to this charity) — a starting list for fundraisers.

Charities like this

Semantically similar by activities and financial character, from our analysed corpus. Compare with CANCER RESEARCH WALES.

Side by side with its peers

CharityIncomeTop pay bandStaff >£60kReserves vs policyFundraising costGoing concern
NATIONAL CANCER RESEARCH INSTITUTE£1.6m——above—no doubt
CANCER RESEARCH WALES FY2026£5.9m——unclear—no doubt
CANCER RESEARCH UK FY2025£734.8m—380above22.0%no doubt
THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY FY2025£433k£70,001 - £80,0001unclear6.0%no doubt
CANCER RESEARCH AND GENETICS UK FY2025£128k—0unclear—no doubt
THE CANCER TREATMENT AND RESEARCH TRUST CIO FY2024£502k—0above—no doubt

Each row is that charity’s latest analysed filing; every value is quote-backed on its own page.